Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans

作者: Rachel Hertz , Jacob Bar-Tana

DOI: 10.1016/S0378-4274(98)00290-2

关键词:

摘要: Amphipathic carboxylates collectively defined as peroxisome proliferators (PP) induce in rodents a pleiotropic effect, mediated by the proliferator-activated receptor alpha (PPAR alpha). Treatment with PP results hypolipidemia, proliferation and liver hypertrophy hyperplasia leading to non-genotoxic hepatocarcinogenesis. In contrast rodents, hypolipidemic effect exerted humans is not accompanied nor induction of peroxisomal beta-oxidation or other activities induced rodents. Non-responsiveness may be ascribed missing component PPAR transduction pathway specifically involved transcriptional modulation chromosomal responsive genes. Hence, biological effects human are likely independent alpha.

参考文章(90)
Naoto Kubota, Yasuo Terauchi, Hiroshi Miki, Hiroyuki Tamemoto, Toshimasa Yamauchi, Kajuro Komeda, Shinobu Satoh, Ryosuke Nakano, Chikara Ishii, Takuya Sugiyama, Kazuhiro Eto, Yoshiharu Tsubamoto, Akira Okuno, Koji Murakami, Hisahiko Sekihara, Go Hasegawa, Makoto Naito, Yasushi Toyoshima, Satoshi Tanaka, Kunio Shiota, Toshio Kitamura, Toshiro Fujita, Osamu Ezaki, Shinichi Aizawa, Ryozo Nagai, Kazuyuki Tobe, Satoshi Kimura, Takashi Kadowaki, PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance Molecular Cell. ,vol. 4, pp. 597- 609 ,(1999) , 10.1016/S1097-2765(00)80210-5
Simon M. Jackson, Farhad Parhami, Xiao-Ping Xi, Judith A. Berliner, Willa A. Hsueh, Ronald E. Law, Linda L. Demer, Peroxisome Proliferator–Activated Receptor Activators Target Human Endothelial Cells to Inhibit Leukocyte–Endothelial Cell Interaction Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 19, pp. 2094- 2104 ,(1999) , 10.1161/01.ATV.19.9.2094
Kenneth W. M. Lawrie, Gregory J. Murphy, Richard M. Hindley, Barrie C. C. Cantello, John C. Clapham, Alison J. Latter, Helen Chapman, Paul J. Coyle, Stephen A. Smith, Julie C. Holder, Lynne Roxbee Cox, David Haigh, Derek R. Buckle, Danuta Mossakowska, Howard Kallender, Paul W. Young, Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. Journal of Pharmacology and Experimental Therapeutics. ,vol. 284, pp. 751- 759 ,(1998)
P Tontonoz, E Hu, R A Graves, A I Budavari, B M Spiegelman, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes & Development. ,vol. 8, pp. 1224- 1234 ,(1994) , 10.1101/GAD.8.10.1224
Sambasiva M. Rao, Janardan K. Reddy, Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. ,vol. 8, pp. 631- 636 ,(1987) , 10.1093/CARCIN/8.5.631
Shinji Kitamura, Yoshiji Miyazaki, Yasuhisa Shinomura, Shinya Kondo, Shuji Kanayama, Yuji Matsuzawa, Peroxisome Proliferator-activated Receptor γ Induces Growth Arrest and Differentiation Markers of Human Colon Cancer Cells Japanese Journal of Cancer Research. ,vol. 90, pp. 75- 80 ,(1999) , 10.1111/J.1349-7006.1999.TB00668.X
Jeffrey M. Gimble, Claudius E. Robinson, Claudius E. Robinson, Steven A. Kliewer, Jurgen M. Lehmann, Brenda R. Rodriguez, Katherine A. Kelly, Katherine A. Kelly, Xiying Wu, David C. Morris, Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Molecular Pharmacology. ,vol. 50, pp. 1087- 1094 ,(1996)
Michael Ristow, Dirk Müller-Wieland, Andreas Pfeiffer, Wilhelm Krone, C. Ronald Kahn, Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. The New England Journal of Medicine. ,vol. 339, pp. 953- 959 ,(1998) , 10.1056/NEJM199810013391403
J.D. Tugwood, I. Issemann, R.G. Anderson, K.R. Bundell, W.L. McPheat, S. Green, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. The EMBO Journal. ,vol. 11, pp. 433- 439 ,(1992) , 10.1002/J.1460-2075.1992.TB05072.X